Centro Salud Ciudad Jardín
- Address
- C. Sancho Miranda 9, 29014 Málaga, Spain
Centro Salud Ciudad Jardín - COVID-19 Research Center
Centro Salud Ciudad Jardín is a clinical research facility dedicated to advancing the treatment of infectious diseases, with particular expertise in COVID-19 therapeutic interventions. The center specializes in conducting outpatient-focused clinical trials that evaluate novel antiviral therapies and their impact on disease progression in high-risk populations.
- COVID-19 antiviral therapy evaluation in outpatient settings
- Clinical efficacy assessment of novel therapeutic agents including Bemnifosbuvir
- High-risk patient population management and hospitalization prevention strategies
The center's research portfolio emphasizes pragmatic clinical endpoints such as all-cause hospitalization and mortality reduction in patients receiving supportive care. Through rigorous placebo-controlled trial designs, Centro Salud Ciudad Jardín contributes valuable evidence for emerging infectious disease treatments, focusing on interventions that can be administered in outpatient settings to prevent disease progression and reduce healthcare burden.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centro Salud Ciudad Jardín
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Bemnifosbuvir Hemisulfate Efficacy and Safety in High-Risk COVID-19 Outpatients: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial | Atea Pharmaceuticals Inc. | Phase III | Not Recruiting | Mar 2023 | May 2024 |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Bemnifosbuvir Hemisulfate | 1 | Unknown | 2023-03-06 | 2023-03-06 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.